Washington Legislative Update

Jenna Stern, Associate Vice President of Regulatory Affairs & Public Policy, supports Vizient’s government relations, monitors federal regulatory and legislative developments, and helps communicate Vizient’s positions on developments most relevant to Vizient and its members. Prior to joining Vizient, Jenna served as the Director of Health Policy for the American Pharmacists Association and as a senior associate with Avalere, a DC-based healthcare consulting firm.

Jenna received her law degree with a concentration in health law from Case Western Reserve University and is a member of the Maryland bar. She is also a graduate of Brock University where she received her bachelor of science in health sciences.

Jenna Stern, Associate VP of Regulatory Affairs & Public Policy at Vizient provides overview of presentation.
Jenna Stern, Associate VP of Regulatory Affairs & Public Policy at Vizient provides overview of presentation.

LEARNING OBJECTIVES

• Describe actions Congress and the Administration have recently taken related to the pharmaceutical supply chain and drug pricing
• Give examples of steps government agencies have taken given the May 11, 2023 end to the COVID-19 public health emergency
• Discuss anticipated federal legislative and regulatory issues that will impact pharmacists for the year ahead

Latest Videos
View all Videos
Executive Insights
May 14, 2024

Pharmacy Angle meets with Sarah Newberry, Assistant Director of Pharmacy Services at Arkansas Methodist Medical Center, to discuss her experience and insights on the pharmacy profession from within a community owned facility.

Executive Insights
May 07, 2024

Pharmacy Angle meets with Valerie Hoffman, Senior Marketing Manager at Long Grove Pharmaceuticals, to discuss her career move from hospital pharmacist to working at a pharmaceutical company.

Executive Insights
Apr 30, 2024

Pharmacy Angle meets with Ken Gagnon, AVP Pharmacy Services HealthTrust Performance Group to discuss his career in pharmacy, encouraging the study of pharmacy and his experience with control, diversion and drug shortage solutions in the hospital setting.